MFN2 is involved in various diseases such as pulmonary fibrosis (Chung, et al. 2019), nonalcoholic fatty liver disease (NAFLD) (Bórquez, et al. 2024), and myocardial lipotoxicity (Hu, et al. 2024). Here, MFN2 is linked to pulmonary fibrosis.